Back to Search
ANDREAS MAUER, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1477739597IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
244155(NY)
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
246770(MA)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
16397(NV)A145769(CA)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
UNIVERSITY OF CHICAGO, PRITZKER SCHOOL OF MEDICINE
Class of 2005
Research & Publications (20)
A phase II study of ABT-751 in patients with advanced non-small cell lung cancer.
PMID 18520803·J Thorac Oncol·2008
3-trial
The role of cooperative groups in cancer clinical trials.
PMID 17305018·Cancer Treat Res·2007
6-review
Bilateral total knee arthroplasty increases the propensity to trip on an obstacle.
PMID 15805952·Clin Orthop Relat Res·2005
4-observational
Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.
PMID 15919687·Ann Oncol·2005
3-trial
Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer.
PMID 12702526·Ann Oncol·2003
3-trial
Calmodulin-like protein upregulates myosin-10 in human keratinocytes and is regulated during epidermal wound healing in vivo.
PMID 18818677·J Invest Dermatol·2009
8-other
Adjuvant chemotherapy in older women with early-stage breast cancer.
PMID 19439741·N Engl J Med·2009
4-observational
A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer.
PMID 19208430·Cancer·2009
3-trial
Interaction with the IQ3 motif of myosin-10 is required for calmodulin-like protein-dependent filopodial extension.
PMID 18570893·FEBS Lett·2008
8-other
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
PMID 18281656·J Clin Oncol·2008
3-trial
Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.
PMID 18978566·J Thorac Oncol·2008
3-trial
Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
PMID 18758303·J Thorac Oncol·2008
3-trial
Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program.
PMID 18823273·Infect Control Hosp Epidemiol·2008
8-other
Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
PMID 18166842·J Thorac Oncol·2008
3-trial
Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction.
PMID 17616302·J Am Coll Cardiol·2007
8-other
The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with gefitinib.
PMID 17473657·J Thorac Oncol·2007
8-other
Status and plans for implementation of NRC regulatory authority for certain naturally occurring and accelerator-produced radioactive material.
PMID 17537736·J Nucl Med Technol·2007
8-other
Effect of bundle branch block on microvolt T-wave alternans and electrophysiologic testing in patients with ischemic cardiomyopathy.
PMID 17599676·Heart Rhythm·2007
8-other
A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer.
PMID 17882655·Cancer Invest·2007
3-trial
Effect of oral beta-blocker therapy on microvolt T-wave alternans and electrophysiology testing in patients with ischemic cardiomyopathy.
PMID 17307418·Am Heart J·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 301 W Huntington Dr Ste 500
Arcadia, CA 91007 - Phone
- (626) 294-4888
Quick Facts
- NPI
- 1477739597
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile